Table 1.
Study | Number of hips | Type of implant | Average age (years) | Duration (years) | Penetration or wear rate | Method of measurement | Findings |
---|---|---|---|---|---|---|---|
Charnley and Halley [2] | 72 | Charnley | 63 | 9–10 | Penetration | Charnley | Progressive decrease in rate until Year 4 and no increase thereafter |
Issac et al. [8] | 87 | Charnley | 55 | 9.25 | Penetration | Shadowgraph of explants | No increase in penetration rate with time after the initial peak |
Pedersen et al. [22]* | 197 | Charnley | 66.3 | 10+ | Wear | Iowa | No evidence of mid- or late-term acceleration of polyethylene wear; essentially constant wear rates for individual patients |
Orishimo et al. [20] | 31 | AML® gamma sterilized | 51.9 | 17 | Wear | Martell | No evidence to support that wear rates were increasing for individual patients |
28 | AML® ETO sterilized | 54.7 | 14 | Wear | Martell | No evidence to support that wear rates were increasing for individual patients | |
Dai et al. [3] | 38 | Omnifit® | 56.7 | 10.9 | Penetration | Two-dimensional computer method | No evidence to support that wear rates were increasing for individual patients |
Goosen et al. [4] | 93 | Biomet® gamma-in-air sterilized | 50 | 8.2 (3–12) | Wear | Livermore | Increase in wear rates after Year 6 |
Goosen et al. [5] | 79 | Biomet® gamma-in-argon sterilized | 55 | 7.5 (3–12) | Wear | Livermore | No evidence to support that wear rates were increasing for individual patients |
* Steady state refers to the rate after the bedding-in period; MOP = metal-on-polyethylene; AML® = Anatomic Medullary Locking; ETO = ethylene oxide.